SCHEMBL24696128

SCHEMBL24696128

CCOC(=O)c1cc2nc(COC3CCCCCC3)cc(C(C)C)n2n1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ LNPEP Q9UIQ6 1/20 0.37
▸ FAAH O00519 6/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TP53 P04637 2/20 0.36
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ MGLL Q99685 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24695823 0.99 KDM4E (0.37) SMN1; SMN2LNPEPFAAHKDM4EALDH1A1
SCHEMBL24696126 0.89 KDM4E (0.37) SMN1; SMN2LNPEPFAAHKDM4EALDH1A1
SCHEMBL24695830 0.88 KDM4E (0.38) LNPEPFAAHKDM4EALDH1A1POLB
SCHEMBL24696130 0.87 SMN1; SMN2 (0.40) SMN1; SMN2FAAHKDM4EALDH1A1POLB
SCHEMBL24696129 0.86 SMN1; SMN2 (0.39) SMN1; SMN2FAAHKDM4EALDH1A1POLB
SCHEMBL24695973 0.86 SMN1; SMN2 (0.39) SMN1; SMN2FAAHKDM4EALDH1A1POLB
SCHEMBL24695643 0.86 SMN1; SMN2 (0.39) SMN1; SMN2FAAHKDM4EALDH1A1POLB
SCHEMBL24695833 0.86 KDM4E (0.39) SMN1; SMN2FAAHKDM4EALDH1A1POLB
SCHEMBL24696342 0.85 KDM4E (0.38) SMN1; SMN2FAAHKDM4EALDH1A1POLB
SCHEMBL24695831 0.85 KDM4E (0.38) SMN1; SMN2FAAHKDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022255408-A1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-12-08 — — WO disclosed
Send feedback